Skip to main content

HB 1574

AN ACT relating to the medical use of low-THC cannabis by patients with

House Bill Jones, Venton
Filed

Filed

Bill introduced by legislator

Committee

Hearing

Passed Cmte

Calendar

Passed

Sent

Enrolled

Governor

Signed

89th Regular Session

Jan 14, 2025 - Jun 2, 2025 • Session ended

Awaiting Committee Assignment

Bill filed, pending referral to House committee

← Back to Bills

Committee

Not yet assigned

Fiscal Note

Not available

What This Bill Does

Expands medical access to low-THC cannabis for Texas patients with specific medical conditions, including amyotrophic lateral sclerosis, neurodegenerative disorders, post-traumatic stress disorder, chronic pain, and other debilitating conditions where opioids might otherwise be prescribed. To qualify, patients must be permanent Texas residents, and physicians must register with the state and certify that the potential medical benefits outweigh the risks. The law will take effect on September 1, 2025, allowing the Department of State Health Services to further define qualifying medical conditions.

Subject Areas

Bill Text

relating to the medical use of low-THC cannabis by patients with
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Section 169.001(3), Occupations Code, is amended
(3)  "Low-THC cannabis" means the plant Cannabis sativa
L., and any part of that plant or any compound, manufacture, salt,
derivative, mixture, preparation, resin, or oil of that plant that
contains not more than 10 milligrams [one percent by weight] of
tetrahydrocannabinols in each dosage unit.
SECTION 2.  Section 169.003, Occupations Code, is amended to
Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS.  (a)  A
physician described by Section 169.002 may prescribe low-THC
(1)  the patient is a permanent resident of the state;
(2)  the physician complies with the registration
requirements of Section 169.004; and
(3)  the physician certifies to the department that:
(A)  the patient is diagnosed with:
(v)  amyotrophic lateral sclerosis;
(viii)  an incurable neurodegenerative
(ix)  post-traumatic stress disorder; [or]
(x)  a condition that causes chronic pain,
for which a physician would otherwise prescribe an opioid;
(xi)  a medical condition that is approved
for a research program under Subchapter F, Chapter 487, Health and
Safety Code, and for which the patient is receiving treatment under
(xii)  a debilitating medical condition
designated by the Department of State Health Services under
(B)  the physician determines the risk of the
medical use of low-THC cannabis by the patient is reasonable in
light of the potential benefit for the patient.
(b)  The Department of State Health Services by rule may
designate debilitating medical conditions for which a physician may
prescribe low-THC cannabis under this section.
SECTION 3.  This Act takes effect September 1, 2025.

Bill Sponsors

Legislators who authored or co-sponsored this bill.

Bill History

filed

Bill filed: AN ACT relating to the medical use of low-THC cannabis by patients with